ASET JAPAN

ASET-JAPAN The Acetyl Salicylic Elimination Trial

ASET-JAPAN The Acetyl Salicylic Elimination Trialお問い合わせ

エンドポイント

主要虚血性エンドポイント
CCS患者の場合は3か月（フェーズ1）、NSTE-ACS患者の場合は12か月（フェーズ2）心臓死、標的血管心筋梗塞（自発性：PCI後48時間以上）、またはのステント血栓症の複合評価項目
主要出血エンドポイント
CCS患者の場合は3か月（フェーズ1）、NSTE-ACS患者の場合は12か月（フェーズ2）BARC type 3または5の出血
副次的評価項目（各フォローアップ訪問/連絡時に評価）
全死亡、脳卒中、すべての（自発性）MI、TLR、Definite/Probable/Possibleのステント血栓症、BARC type 1-5の出血、および主要評価項目の各要素。

References

  1. Kogame N, Guimarães PO, Modolo R, De Martino F, Tinoco J, Ribeiro EE, Kawashima H, Ono M, Hara H, Wang R, Cavalcante R, Moulin B, Falcão BAA, Leite RS, de Almeida Sampaio FB, Morais GR, Meireles GC, Campos CM, Onuma Y, Serruys PW, Lemos PA. Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study. JACC Cardiovasc Interv 2020;13(19):2251-2262.
  2. Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 2007;50(4):309-15.
  3. Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, Taubert K, Smith SC, Jr. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol 2014;11(10):597-606.
  4. Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Nakamura M. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J 2014;78(7):1684-92.
  5. Nakamura M, Kozuma K, Kitazono T, Iizuka T, Sekine T, Shiosakai K, Usui I, Kogure S. Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)　- A 3-Month Interim Analysis of a Postmarketing Observational Study. Circ J 2019;83(3):637-646.
  6. Nakamura M, Morino Y, Kakuta T, Hata Y, Takamisawa I, Tanabe K, Anzai H, Takahashi A, Kadota K, Suzuki H, Wakatsuki T, Okayama H, Yamashita J, Akasaka T, Yokoi H, Nakagami T, Higuchi Y, Yamaguchi J, Kimura T, Harada A, Kuroda T, Takita A, Iijima R, Murakami Y, Saito S. Monotherapy With Prasugrel After Dual-Antiplatelet Therapy for Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk　- A Prospective Cohort Study (PENDULUM mono Study). Circ J 2020;85(1):27-36.